News

Catena Biosciences Expands Executive Leadership Team, Appoints Saurabh Johri as Chief Business Officer and Rick Kendall as Chief Scientific Officer

July 27, 2023 | Berkeley, CA

Catena Biosciences, Inc., a biotechnology company pioneering protein conjugation technologies for novel therapeutic development, today announced the expansion of its leadership team with two new executive appointments. The company has appointed Saurabh Johri as Chief Business Officer and Rick Kendall, Ph.D. as Chief Scientific Officer.

Modification of Cysteine-Substituted Antibodies Using Enzymatic Oxidative Coupling Reactions

February 14, 2023

Tyrosinase-Mediated Synthesis of Nanobody–Cell Conjugates

June 22, 2022

Synthesis of Multi-Protein Complexes through Charge-Directed Sequential Activation of Tyrosine Residues

August 12, 2021

Protein–Protein Conjugates: Tyrosine Delivers

August 25, 2020

Site-Specific Bioconjugation through Enzyme-Catalyzed Tyrosine–Cysteine Bond Formation

August 21, 2020

Tyrosinase-Mediated Oxidative Coupling of Tyrosine Tags on Peptides and Proteins

February 24, 2020

Leading the Charge in Targeting and Connecting Proteins

With our technology, synthesize novel biomolecules in any structure, combination, or orientation.

Partner with us